BRISTOL MYERS SQUIBB CO Investing Cash Flow 2007-2026 | BMY
Beta
What is investing cash flow?
Investing cash flow represents cash used for or generated from investment activities, including capital expenditures, acquisitions, and investment purchases or sales.
What is BRISTOL MYERS SQUIBB CO's current investing cash flow?
BRISTOL MYERS SQUIBB CO (BMY) annual investing cash flow for 2025 was $-4.13B, a 80.65% increase from 2024. BRISTOL MYERS SQUIBB CO investing cash flow for the quarter ending March 31, 2026 was $-131.0M.
What was BRISTOL MYERS SQUIBB CO's investing cash flow in 2024?
BRISTOL MYERS SQUIBB CO annual investing cash flow for 2024 was $-21.35B, a 830.37% decline from 2023.
What was BRISTOL MYERS SQUIBB CO's investing cash flow in 2023?
BRISTOL MYERS SQUIBB CO annual investing cash flow for 2023 was $-2.29B, a 116.10% decline from 2022.
Investing Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$-10.86B
→
FY2025
$-4.13B
07080910111213141516171819202122232425
5 years selected
Investing Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-4.13B | +80.6% | 10-K |
| FY2024 | $-21.35B | -830.4% | 10-K |
| FY2023 | $-2.29B | -116.1% | 10-K |
| FY2022 | $-1.06B | -97.4% | 10-K |
| FY2021 | $-538.0M | +95.0% | 10-K |
| FY2020 | $-10.86B | -9.5% | 10-K |
| FY2019 | $-9.91B | -395.7% | 10-K |
| FY2018 | $-2.00B | -2930.3% | 10-K |
| FY2017 | $-66.0M | -104.5% | 10-K |
| FY2016 | $1.48B | +194.1% | 10-K |
| FY2015 | $-1.57B | -229.3% | 10-K |
| FY2014 | $1.22B | +312.6% | 10-K |
| FY2013 | $-572.0M | +91.5% | 10-K |
| FY2012 | $-6.73B | -368.1% | 10-K |
| FY2011 | $-1.44B | +62.3% | 10-K |
| FY2010 | $-3.81B | +13.0% | 10-K |
| FY2009 | $-4.38B | -186.2% | 10-K |
| FY2008 | $5.08B | +2614.4% | 10-K |
| FY2007 | $-202.0M | - | 10-K |
Company: BRISTOL MYERS SQUIBB COTicker: BMYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →